Jeff Fairman - 16 Dec 2021 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
VP, Research
Signature
/s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
PCVX
Transactions as of
16 Dec 2021
Net transactions value
-$95,659
Form type
4
Filing time
20 Dec 2021, 15:35:34 UTC
Previous filing
13 Dec 2021
Next filing
08 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Options Exercise $8,268 +4,619 +75% $1.79* 10,779 16 Dec 2021 Direct
transaction PCVX Common Stock Sale $103,928 -4,619 -43% $22.50 6,160 16 Dec 2021 Direct F1
holding PCVX Common Stock 341,227 16 Dec 2021 By Fairman Family Trust
holding PCVX Common Stock 50,000 16 Dec 2021 By AF 2020 Irrevocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (right to buy) Options Exercise $0 -4,619 -7.4% $0.000000 58,095 16 Dec 2021 Common Stock 4,619 $1.79 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The shares subject to the option are fully vested and exercisable.